Mynvax: Funding, Investors & Team (Sep 2026)
Mynvax is an Indian biotech startup that focuses on creating advanced flu vaccines. Their technology enables quick, cost-effective production of vaccines on a large scale, which could be crucial for protecting populations during pandemics. Founded in 2017 by Raghavan Varadarajan and Gautham Nadig, Mynvax originated from the Indian Institute of Science.
Mynvax has raised $2.6M across 1 funding round on record, the most recent a Series A of $2.6M announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mynvax Company Profile and Key Stats
Latest funding round on record: May 2024.
Mynvax Funding Rounds
Mynvax Founders and Leadership Team
Contact details for the Mynvax team: 1 of 1 has an email address on file.
Start 14-day free trial →Mynvax Funding Compared to Other Biotechnology Startups
Mynvax's latest round of $2.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mynvax in Biotechnology and Bangalore
Companies Similar to Mynvax
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein…
Cellarim is at the forefront of the biomanufacturing revolution. As a pioneer in the biotechnology business,…
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell…
QRL Bioscience is a science and technology-focused company dedicated to finding solutions for diabetic foot…
Ivory improves the aging process by promoting sharper thinking and better living. They assist in the early…
Prantae Solutions is a biotechnology company that develops cost-effective technologies for uncommon and…
ErlySign creates home-based early detection test kits for life-threatening illnesses such as Oral cancer,…
BrainSightAI is a software platform that uses MRI technology to improve accuracy in neurological and…
Mynvax Funding FAQs
What does Mynvax do?
Mynvax is an Indian biotech startup that focuses on creating advanced flu vaccines. Their technology enables quick, cost-effective production of vaccines on a large scale, which could be crucial for protecting populations during pandemics. Founded in 2017 by Raghavan Varadarajan and Gautham Nadig, Mynvax originated from the Indian Institute of Science.
How much funding has Mynvax raised?
Mynvax has raised $2.6M across 1 round on record. The most recent is a Series A of $2.6M announced in May 2024.
When did Mynvax last raise funding?
Mynvax's most recent funding round on record is a Series A of $2.6M, announced in May 2024.
Who founded Mynvax?
FundedIQ lists Raghavan Varadarajan (Founder) at Mynvax.
Where is Mynvax headquartered?
Mynvax is based in Bangalore, Karnataka, India.
How many employees does Mynvax have?
Mynvax is in the 11-50 employee band.
How does Mynvax's funding compare to other Biotechnology startups?
Mynvax's latest round of $2.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Mynvax Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mynvax is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.